Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 3/2012

01-04-2012

Isolated calf deep vein thrombosis in the community setting: the Worcester Venous Thromboembolism study

Authors: Frederick A. Spencer, Aimee Kroll, Darleen Lessard, Cathy Emery, Alla V. Glushchenko, Luigi Pacifico, George Reed, Joel M. Gore, Robert J. Goldberg

Published in: Journal of Thrombosis and Thrombolysis | Issue 3/2012

Login to get access

Abstract

The prevalence of isolated calf deep vein thrombosis (DVT) in the community setting is relatively unexplored. Confusion remains with regards to its management and contemporary natural history. The purpose of this investigation was to describe the number of cases of calf DVT in the community, use of early management strategies, and rates of venous thromboembolism (VTE) recurrence and major bleeding. The medical records of residents of the Worcester (MA) metropolitan area with ICD-9 codes consistent with potential VTE during 4 study years (1999/2001/2003/2005) were validated by trained nurses. Patient demographic/clinical characteristics, treatment practices, and outcomes were evaluated. Isolated calf DVT was diagnosed in 166 (11.1%) of 1,495 patients with lower extremity DVT. Patients with calf DVT were less likely to be discharged on anticoagulants or with an IVC filter than patients with proximal DVT (84.1 vs. 92.3%). The rates of VTE recurrence and pulmonary embolism did not differ significantly between patients with calf DVT and proximal DVT at 6 months (11.0 vs. 8.7%, 2.6 vs. 1.8%, respectively). Patients with calf DVT had higher adjusted risk of early (14-day) VTE recurrence/extension (OR 2.34, 95% CI 1.01–5.44). Patients with calf DVT had lower rates of major bleeding at 6 months compared to patients with proximal DVT (5.2 vs. 9.3%, P = 0.04). Rates of recurrent VTE and major bleeding following calf DVT in the community are much higher than in randomized clinical trials of patients with proximal or calf DVT. Further study of management strategies for isolated calf DVT is needed.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lagerstedt CI, Olsson CG, Fagher BO, Oqvist BW, Albrechtsson U (1985) Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet 2:515–518PubMedCrossRef Lagerstedt CI, Olsson CG, Fagher BO, Oqvist BW, Albrechtsson U (1985) Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet 2:515–518PubMedCrossRef
2.
go back to reference Lohr JM, Kerr TM, Lutter KS, Cranley RD, Spirtoff K, Cranley JJ (1991) Lower extremity calf thrombosis: to treat or not to treat? J Vasc Surg 14:618–623PubMedCrossRef Lohr JM, Kerr TM, Lutter KS, Cranley RD, Spirtoff K, Cranley JJ (1991) Lower extremity calf thrombosis: to treat or not to treat? J Vasc Surg 14:618–623PubMedCrossRef
3.
go back to reference Labropoulos N, Kang SS, Mansour MA, Giannoukas AD, Moutzouros V, Baker WH (2002) Early thrombus remodelling of isolated calf deep vein thrombosis. Eur J Vasc Endovasc Surg 23:344–348PubMedCrossRef Labropoulos N, Kang SS, Mansour MA, Giannoukas AD, Moutzouros V, Baker WH (2002) Early thrombus remodelling of isolated calf deep vein thrombosis. Eur J Vasc Endovasc Surg 23:344–348PubMedCrossRef
4.
go back to reference Moreno-Cabral R, Kistner RL, Nordyke RA (1976) Importance of calf vein thrombophlebitis. Surgery 80:735–742PubMed Moreno-Cabral R, Kistner RL, Nordyke RA (1976) Importance of calf vein thrombophlebitis. Surgery 80:735–742PubMed
5.
go back to reference Partsch H (2001) Therapy of deep vein thrombosis with low molecular weight heparin, leg compression and immediate ambulation. Vasa 30:195–204PubMedCrossRef Partsch H (2001) Therapy of deep vein thrombosis with low molecular weight heparin, leg compression and immediate ambulation. Vasa 30:195–204PubMedCrossRef
6.
go back to reference Cogo A, Lensing AW, Koopman MM et al (1998) Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study. BMJ 316:17–20PubMedCrossRef Cogo A, Lensing AW, Koopman MM et al (1998) Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study. BMJ 316:17–20PubMedCrossRef
7.
go back to reference Birdwell BG, Raskob GE, Whitsett TL et al (1998) The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosis. Ann Intern Med 128:1–7PubMed Birdwell BG, Raskob GE, Whitsett TL et al (1998) The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosis. Ann Intern Med 128:1–7PubMed
8.
go back to reference Spencer FA, Emery C, Joffe SW et al (2009) Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study. J Thromb Thrombolysis 28:401–409PubMedCrossRef Spencer FA, Emery C, Joffe SW et al (2009) Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study. J Thromb Thrombolysis 28:401–409PubMedCrossRef
9.
go back to reference Silverstein MD, Heit JA, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ III (1998) Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 158:585–593PubMedCrossRef Silverstein MD, Heit JA, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ III (1998) Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 158:585–593PubMedCrossRef
10.
go back to reference Schulman S, Kearon C (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3:692–694PubMedCrossRef Schulman S, Kearon C (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3:692–694PubMedCrossRef
11.
go back to reference Palareti G, Cosmi B, Lessiani G et al (2010) Evolution of untreated calf deep-vein thrombosis in high risk symptomatic outpatients: the blind, prospective CALTHRO study. Thromb Haemost 104:1063–1070PubMedCrossRef Palareti G, Cosmi B, Lessiani G et al (2010) Evolution of untreated calf deep-vein thrombosis in high risk symptomatic outpatients: the blind, prospective CALTHRO study. Thromb Haemost 104:1063–1070PubMedCrossRef
12.
go back to reference Lohr JM, Fellner AN (2010) Isolated calf vein thrombosis should be treated with anticoagulation. Dis Mon 56:590–600PubMedCrossRef Lohr JM, Fellner AN (2010) Isolated calf vein thrombosis should be treated with anticoagulation. Dis Mon 56:590–600PubMedCrossRef
13.
go back to reference Masuda EM, Kistner RL (2010) The case for managing calf vein thrombi with duplex surveillance and selective anticoagulation. Dis Mon 56:601–613PubMedCrossRef Masuda EM, Kistner RL (2010) The case for managing calf vein thrombi with duplex surveillance and selective anticoagulation. Dis Mon 56:601–613PubMedCrossRef
14.
go back to reference Bernardi E, Camporese G, Buller HR et al (2008) Serial 2-point ultrasonography plus D-dimer vs whole-leg color-coded Doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis: a randomized controlled trial. Jama 300:1653–1659PubMedCrossRef Bernardi E, Camporese G, Buller HR et al (2008) Serial 2-point ultrasonography plus D-dimer vs whole-leg color-coded Doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis: a randomized controlled trial. Jama 300:1653–1659PubMedCrossRef
15.
go back to reference Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ (2008) Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133:454S–545SPubMedCrossRef Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ (2008) Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133:454S–545SPubMedCrossRef
16.
go back to reference Decousus H, Leizorovicz A, Parent F et al (1998) A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d’Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 338:409–415PubMedCrossRef Decousus H, Leizorovicz A, Parent F et al (1998) A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d’Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 338:409–415PubMedCrossRef
17.
go back to reference Fiessinger JN, Huisman MV, Davidson BL et al (2005) Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial. JAMA 293:681–689PubMedCrossRef Fiessinger JN, Huisman MV, Davidson BL et al (2005) Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial. JAMA 293:681–689PubMedCrossRef
18.
go back to reference Buller HR, Davidson BL, Decousus H et al (2004) Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial. Ann Intern Med 140:867–873PubMed Buller HR, Davidson BL, Decousus H et al (2004) Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial. Ann Intern Med 140:867–873PubMed
19.
go back to reference Pinede L, Ninet J, Duhaut P et al (2001) Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation 103:2453–2460PubMed Pinede L, Ninet J, Duhaut P et al (2001) Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation 103:2453–2460PubMed
20.
go back to reference Schulman S, Rhedin AS, Lindmarker P et al (1995) A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med 332:1661–1665PubMedCrossRef Schulman S, Rhedin AS, Lindmarker P et al (1995) A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med 332:1661–1665PubMedCrossRef
21.
go back to reference Hansson PO, Sorbo J, Eriksson H (2000) Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med 160:769–774PubMedCrossRef Hansson PO, Sorbo J, Eriksson H (2000) Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med 160:769–774PubMedCrossRef
22.
go back to reference Heit JA, Mohr DN, Silverstein MD, Petterson TM, O’Fallon WM, Melton LJ 3rd (2000) Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 160:761–768PubMedCrossRef Heit JA, Mohr DN, Silverstein MD, Petterson TM, O’Fallon WM, Melton LJ 3rd (2000) Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 160:761–768PubMedCrossRef
Metadata
Title
Isolated calf deep vein thrombosis in the community setting: the Worcester Venous Thromboembolism study
Authors
Frederick A. Spencer
Aimee Kroll
Darleen Lessard
Cathy Emery
Alla V. Glushchenko
Luigi Pacifico
George Reed
Joel M. Gore
Robert J. Goldberg
Publication date
01-04-2012
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 3/2012
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-011-0670-x

Other articles of this Issue 3/2012

Journal of Thrombosis and Thrombolysis 3/2012 Go to the issue